Skip to main content
. 2021 Feb 15;18(1):105–119. doi: 10.20892/j.issn.2095-3941.2020.0098

Figure 4.

Figure 4

HBXIP prevents proteasome-mediated MEK1 degradation. (A) MEK1 protein stability in HBXIP-deficient A549 and H1299 cells was assessed by Western blot (left panel), and protein levels were quantified (right panel) after cells were treated with cycloheximide for 2 or 4 h. (B) Western blot of MEK1 protein in HBXIP knockdown A549 and H1299 cells treated with MG132 for 2 and 4 h. (C) Immunofluorescence staining of HBXIP and MEK1 in HBXIP-overexpressing A549 cells and the quantified staining intensity of HBXIP and MEK1 (lower panel). Scale bars, 50 μm. (D) Immunoprecipitation of MEK1 by anti-FLAG beads in cell extracts of A549 cells overexpressing FLAG-tagged HBXIP. The results were analyzed by an unpaired t-test. **P < 0.01; ***P < 0.001.